Glaukos GKOS Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Corneal Health | $89.16M+3.2% | $86.37M+3.1% | $83.76M+3.3% | $81.11M+1.0% | $80.33M+0.2% | |
| Glaucoma | $462.19M+9.8% | $421.07M+9.1% | $386.06M+9.7% | $351.85M+8.5% | $324.19M+6.9% | |
| Revenue by Geography | ||||||
| Non Us | $139.03M+5.0% | $132.4M+4.1% | $127.21M+4.5% | $121.78M+4.0% | $117.05M+3.2% | |
| US | $412.32M+9.9% | $375.04M+9.5% | $342.61M+10.1% | $311.18M+8.2% | $287.48M+6.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Glaukos break its business down?
- Glaukos (GKOS) reports revenue by product across 2 parts — Corneal Health and Glaucoma. Each is extracted from the segment footnotes and tracked over time.
- Where does Glaukos's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Glaukos's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
